VU-2735

N/A

Report date: 2025/06/11 10:46:20
NME

Base Information

Drug NameVU-2735
Drug Alias NameDMH-1-derived Alk inhibitors (La Jolla Pharmaceutical/ Vanderbilt University Medical Center)VU-2735VU-2733
ClassificationSmall molecules
Mechanisms of ActionAnaplastic lymphoma kinase inhibitors
TargetsAnaplastic lymphoma kinase
Therapy Area/IndicationsMyositis Ossificans
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLa Jolla Pharmaceutical Company
China Registration ClassN/A

Develop Information

Active CompaniesLa Jolla Pharmaceutical CompanyVanderbilt University
Inactive CompaniesN/A
Active IndicationsMyositis Ossificans
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A